Quantitative CT metrics can be used to define progressive pulmonary fibrosis and have prognostic value in patients with ...

The BMP8A Fibrosis Score (BFS) offers improved accuracy over existing noninvasive scoring systems for identifying advanced liver fibrosis in MASH patients. BFS eliminates grey-zone results, providing ...

Background: The Prognostic Lung Fibrosis Consortium (PROLIFIC) was formed to develop well-qualified assays suitable for use as prognostic biomarkers within the context of clinical trials for Idiopathic ...

Blood-based biomarkers and imaging measures may help monitor MASH disease activity, potentially reducing reliance on liver biopsies. Semaglutide treatment showed significant improvements in liver ...

A new analysis links short and long sleep duration to markers of chronic liver disease, highlighting sleep as a potential ...

ACE inhibitor use was associated with reduced all cause mortality in idiopathic pulmonary fibrosis in a matched real world ...